The comparative safety of first-line conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs) used for the treatment of rheumatoid arthritis: protocol for a multi-database real-world cohort study

ENCePP Code of conduct

No

ENCePP Seal

Signed checklist for study protocols

raple_eupas_checklist

Data sources

• Data source(s):
  THIN® (The Health Improvement Network®)

  The Information System for Research in Primary Care (SIDIAP)
• Data source(s), other:
  THIN, SIDIAP
• Data sources (types):
  Administrative data (e.g. claims)

  Drug dispensing/prescription data

  Electronic healthcare records (EHR)

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  No